Cargando…

Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey

BACKGROUND: Use of atypical antipsychotics (AA) in combination with an antidepressant is recommended as an augmentation strategy for patients with depression. However, there is a paucity of data comparing aripiprazole and other AAs in terms of patient reported outcomes. Therefore, the objective of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalsekar, Iftekhar, Wagner, Jan-Samuel, DiBonaventura, Marco, Bates, Jay, Forbes, Robert, Hebden, Tony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411477/ https://www.ncbi.nlm.nih.gov/pubmed/22805425 http://dx.doi.org/10.1186/1477-7525-10-81

Ejemplares similares

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy
por: Nadkarni, Anagha, et al.
Publicado: (2013)

Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2011)

Psychosocial Comorbidities and Health Status Among Adults with Moderate-to-Severe Atopic Dermatitis: A 2017 US National Health and Wellness Survey Analysis
por: Kwatra, Shawn G., et al.
Publicado: (2021)

A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey
por: Ding, Bo, et al.
Publicado: (2017)

Asthma-chronic obstructive pulmonary disease overlap syndrome in the urban Chinese population: prevalence and disease burden using the 2010, 2012, and 2013 China National Health and Wellness Surveys
por: Ding, Bo, et al.
Publicado: (2016)

Impact of self-rated osteoarthritis severity in an employed population: Cross-sectional analysis of data from the national health and wellness survey
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2012)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Atypical antipsychotics as add-on treatment in late-life depression
por: Cakir, Sibel, et al.
Publicado: (2016)

The association of sleep difficulties with health-related quality of life among patients with fibromyalgia
por: Wagner, Jan-Samuel, et al.
Publicado: (2012)

Oncologists’ Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National Survey
por: Shah-Manek, Bijal, et al.
Publicado: (2018)

Health-related quality of life in patients treated with atypical antipsychotics
por: de Almeida, Juliana L., et al.
Publicado: (2020)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020)

Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017
por: Fulone, Izabela, et al.
Publicado: (2023)

Call to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older Adults
por: Amodeo, Katherine, et al.
Publicado: (2016)

Atypical antipsychotics, dystonia, and psychotic depression: old solutions for new problems
por: Gazzellone, Matthew J., et al.
Publicado: (2022)

Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries
por: Yamabe, Kaoru, et al.
Publicado: (2019)

Burden of air leak complications in thoracic surgery estimated using a national hospital billing database
por: Yoo, Andrew, et al.
Publicado: (2017)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder
por: Seo, Rubo J., et al.
Publicado: (2010)

Atypical antipsychotics and delirium in critical care
por: Wise, Matt P, et al.
Publicado: (2011)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Constrictive Pericarditis Associated with Atypical Antipsychotics
por: Chen, Kuan-chin Jean, et al.
Publicado: (2012)

Pedal edema associated with atypical antipsychotics
por: Munshi, Santanu, et al.
Publicado: (2016)

Predictors of Effect of Atypical Antipsychotics on Speech
por: Sinha, Preeti, et al.
Publicado: (2015)

Clinical pharmacology of atypical antipsychotics: an update
por: Mauri, M.C., et al.
Publicado: (2014)

Anti-stress Properties of Atypical Antipsychotics
por: Sanson, Alice, et al.
Publicado: (2020)

National trends in off-label use of atypical antipsychotics in children and adolescents in the United States
por: Sohn, Minji, et al.
Publicado: (2016)

Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression
por: Chekani, Farid, et al.
Publicado: (2020)

Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis
por: Kadakia, Aditi, et al.
Publicado: (2021)

Burden of peripheral arterial disease in Europe and the United States: a patient survey
por: Marrett, Elizabeth, et al.
Publicado: (2013)

The association between lower back pain and health status, work productivity, and health care resource use in Japan
por: Sadosky, Alesia B, et al.
Publicado: (2015)

Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
por: Broekema, W. J., et al.
Publicado: (2007)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Patient characteristics, treatment patterns, and health outcomes among COPD phenotypes
por: Allen-Ramey, Felicia C, et al.
Publicado: (2012)

Seborrheic Dermatitis: A Case of an Atypical Side Effect of Atypical Antipsychotics
por: Bishay, Ramy, et al.
Publicado: (2023)

The Health and Well-Being of Transgender Australians: A National Community Survey
por: Bretherton, Ingrid, et al.
Publicado: (2021)

The use of atypical antipsychotics in Bipolar Spectrum disorders
por: Grünze, H., et al.
Publicado: (2003)

Asenapine, a new sublingual atypical antipsychotic
por: Balaraman, R, et al.
Publicado: (2010)

Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
por: Lee, Philip E, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_iafm0q61s1i7u410pus6gmi8nt